Brief: Eurofins 9M Revenues €5.61 Bln
BRIEF-Eurofins 9M Revenues €5.61 Bln Oct 21 (Reuters) - Eurofins Scientific SE EUFI.PA:
EUROFINS DELIVERS IMPROVING ORGANIC GROWTH THROUGH 9M 2026; REMAINS ON TRACK FOR 2026 AND MID-TERM PROFITABILITY OBJECTIVES
REPORTED REVENUES IN 9M 2026 TOTAL €5,614M, UP 3.7% VERSUS 9M 2025
EXPECTS 2026 REVENUES FROM ACQUISITIONS ABOVE PREVIOUS OBJECTIVE OF €250M
EXPECTS ADJUSTED EBITDA MARGIN IMPROVEMENT IN 2026 ABOVE FY 2025 MARGIN OF 22.5%
FY 2026 ORGANIC GROWTH IS LIKELY TO BE BELOW PREVIOUS MID-SINGLE-DIGIT OBJECTIVE
Source text: ID:nBw9KB6kHa
Further company coverage: EUFI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;;))
Recent news on Eurofins Scientific SE
See all newsEurope Research Roundup: Avio, Genmab, Veolia
Europe Research Roundup: Avio, Genmab, Kerry Group
Brief: Eurofins 9M Revenues €5.61 Bln
European life sciences stocks rise on strong sector momentum
Brief: Eurofins Completes The Acquisition Of Element Materials Technology’S Life Sciences Testing Services Business